Sleep apnea isn’t just something that affects older adults anymore. Experts say they’re seeing more younger people being ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Sleep apnea often goes untreated because it doesn’t look the way most people expect it to. Many imagine loud, disruptive ...

Obstructive Sleep Apnea (OSA) is a common but often undiagnosed medical condition affecting many Canadians. Characterized by ...

Sleep problems are expanding quickly among children because of inconsistent school schedules and more screen time. Disrupted ...

Graham Goodrich, CCO, Apnimed, outlines how advances in diagnostics, growing recognition of sleep apnea’s systemic impact, ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

You can live for years with obstructive sleep apnea and never know it. The condition repeatedly narrows your upper airway during sleep.

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

New research shows long-term sleep problems may change gut bacteria, increasing inflammation and health risks beyond the ...

AI can use sleep data from a single night to identify patterns linked to disease risk years before symptoms appear.